Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-02-14
1995-01-10
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530350, 530363, 530364, 435 696, A61K 3702
Patent
active
053807120
ABSTRACT:
Polypeptides corresponding to mature human serum albumin residues 1 to n, where n is between 369 and 419 inclusive, are useful as substitutes for albumin in the treatment of burns and shock in humans, the clearance of undesirable compounds, (such as bilirubin) from human blood, in laboratory growth media and in HSA assays. The polypeptides may be produced by recombinant DNA techniques, especially in yeast.
REFERENCES:
Lawn, et al., Nucl. Acids Res. 9, 6102-6114 (1981).
Brown & Schockley, in "Lipid-Protein Interactions", 1, Ed. P. C. Jost (1982).
Galliano, et al., J. Biol. Chem. 261(9), 4283-4287 (1986).
Takahashi, et al., P.N.A.S., 84, 4413-4417 (1987).
Doyen, et al., J. Biol. Chem 257(6), 2770-2774 (1982).
Geisow & Beaven, Biochem. J. 163, 477-484 (1977).
Ballance David J.
Geisow Michael J.
Hinchliffe Edward
Senior Peter J.
Cassett Larry R.
Delta Biotechnology Limited
Draper Garnette D.
Fitzgerald David L.
Swope R. Hain
LandOfFree
Truncated human serum albumin polypeptides as plasma expanding a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Truncated human serum albumin polypeptides as plasma expanding a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Truncated human serum albumin polypeptides as plasma expanding a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-850649